Prelude Therapeutics Inc
NASDAQ:PRLD 11:47:31 AM EDT
Earnings Announcements
Prelude Therapeutics Posts Q1 Loss Per Share $0.63
Published: 05/10/2022 12:21 GMT
Prelude Therapeutics Inc (PRLD) - Q1 Loss per Share $0.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.64
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66
More details on our Analysts Page.